je.st
news
AbbVie boosts cancer drug pipeline with $21 billion Pharmacyclics deal
2015-03-05 13:11:44| Biotech - Topix.net
AbbVie Inc is to buy Pharmacyclics Inc for about $21 billion, giving it access to what is expected to be one of the world's top-selling cancer drugs and expanding its reach in the profitable oncology field. The deal -- the latest example of a big drugmaker swooping on a biotech firm to refill its medicine pipeline -- confounds expectations that Pharmacyclics would sell out to Johnson & Johnson .
Tags: deal
drug
cancer
billion
Category:Biotechnology and Pharmaceuticals